HIGHLIGHTS
- who: Camrelizumab-Related Lethal Arrhythmias and collaborators from the Department of Cardiology, The Second Affiliated Hospital of Chongqing Medical University, No, Tian Wen Nan'an District, Chongqing, China have published the Article: Case Report Camrelizumab-Related Lethal Arrhythmias and Myasthenic Crisis in a Patient with Metastatic Thymoma, in the Journal: Case Reports in Cardiology of 26/03/2022
- what: The authors report a thymoma patient with multiple organ damage after the first dose of camrelizumab, a newly approved ICI .
SUMMARY
Immune checkpoint inhibitors (ICIs) are widely used for treatment of diverse . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.